Bayer was trending down for last almost a year. Now it's seems to draw the double botton. Stock found the support, bounce twice and seems to be recovering. Moreover, the dividend is incomingin near future what could boost the price additionally.
this is not a recomendation, only my guess what could happen
The #EU is Marxist, Socialist, and is involved in Price setting
That didn't work out too well for USSR as economic powerhouse
and so too we see the once great German economy being brought to it's knees.
It is being de-industralized and being brought down in a great economic levelling of the union
Such a shame
Bayer Pharmaceutical is arguably a company we...
Bayer (BAYN): XETR:BAYN
Upon request from one of our members, we're taking a closer look at Bayer AG. We believe that we are still in an overarching Wave II. This wave finds its last true support at the 88.2% retracement level at €24.51. Falling significantly below this level would likely lead us to see a 100% retracement down to €8.48, which would be severe...
In a strategic move to tackle its mounting debt and enhance financial flexibility, Bayer ( OTC:BAYRY ), the German pharmaceutical giant, has announced a significant shift in its dividend policy. The decision, though met with mixed reactions from investors and analysts, underscores the company's commitment to addressing its pressing financial challenges.
Facing...
Retesting the channel price recently broke out of, this represents a possible buy opportunity backed with a recent insider buying activity. First target right after the gap where you could take partials, then 48 EUR. If you believe in the company why not hold to ATH.
Bill Anderson doing the roadshow in Dc and Carlyle Group seems to be
going in heavy at current levels or lower for the next RUN UP
a long game to make a killing for heavy hitters in the pharma bio agri chemical business
the timing to position for such a deal takes time and feel in the this type of business
the usual play is Dress up Window PUMP for public...
After Bayer's stock recently tried to break through the support level of €39.91, it has now made another attempt. Whether the stock succeeds in sustainably breaking below this support level - as envisaged in our primary scenario - or whether it needs further impetus in the form of a corrective upward move is irrelevant for the further course of our expectations....
Bayer AG is a German multinational pharmaceutical and life sciences company founded in 1863. The company is headquartered in Leverkusen, Germany, and employs over 100,000 people worldwide. Bayer's core business areas are human and veterinary pharmaceuticals, consumer healthcare products, agricultural chemicals, and biotechnology products.
Bayer stock is a great...
The technical figure Falling Wedge can be found in the daily chart in the German company Bayer AG (BAYN.de). Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include pharmaceuticals; consumer healthcare products,...
I see this a a company that I could potentially add to the portfolio I have been creating, it consists of assets that I will buy and hold for more than 15 years.
Bayer AG - 30d expiry - We look to Sell at 54.48 (stop at 56.11)
Daily signals are bearish.
54.50 continues to hold back the bulls.
Bespoke resistance is located at 54.50.
Preferred trade is to sell into rallies.
The bearish engulfing candle on the daily chart is negative for sentiment.
Our profit targets will be 50.41 and 49.41
Resistance: 52.00 / 53.20...
Hello dear Traders,
Here is my idea for #BAYN
Price closed above yellow line (previous month high)
Price closed (15min Chart) above purple trigger line to enter trade.
Targets marked in the chart (black lines)
Invalidation level marked with red line
Good luck!
❤️Please feel free to ask any question in comments. I will try to answer all! Thank you.
Please,...
The Elliott-Wave patter appears to be drawn on current Bayer 1h chart. Longterm, after reaching EUR 60 and going down and touching the 40 EUR area, I expect Bayer to recover and aim for its pre-Covid high of around 80 EUR. Fundamentally Bayer is undervalues, also when it comes to some new products that are in the process of being legalized.
After the complete 1-5 Elliot-Wave and the correction wave Bayer is still not in an upward trend. Despite Bayer's technical improvement, the stock is still not in an upward trend, and lower lows are not excluded in the coming quarters.
Currently, it appears that Bayer is beginning to move higher, and €46 in October may have represented a bottom. Although we...
